Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorIstituto Ortopedico Rizzoli
About this trial
Total arthroplasty (THA) is the treatment of choice for severe osteoarthritis of the hip joint. Following this type of intervention, a multidisciplinary rehabilitation approach allows you to reduce pain and improve the ability to carry out activities of daily living (ADL), but it is not clear what the optimal rehabilitation program is. Recently, the use of telerehabilitation has increased over the years. Specifically, in treatment of patients following THA surgery, telerehabilitation is able to give similar results to the treatment performed in person terms of pain and function. The aim of this study is to verify whether telerehabilitation associated with In-person treatment is comparable in terms of pain, recovery functionality and patient participation and satisfaction, compared to those provided by rehabilitation alone in the presence of patients undergoing THA surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having undergone total hip replacement surgery (THA)
Start outpatient treatment within 7 days of discharge from the Orthopedic Department
Age between 50 and 80 years.
Continuation of rehabilitation treatments at the IOR Physical Medicine and Rehabilitation service in Argenta.
Disqualifiers
patients undergoing revision of previous prosthesis surgery
difficulty understanding the Italian language/language barrier
unavailability stable wi-fi connection by the patient
Trial design
Design model
Parallel
Treatments tested in this trial
Telerehabilitation
Other interventionthe patient will undergo 10 session of tele rehabilitation in continuity with traditional physiotherapy
Traditional rehabilitation
Other interventionthe patient will undergo 16 session of outpatient physiotherapy rehabilitation
Treatment groups
104 Participants
are divided into 2 treatment groupsGroup A: TelerehabilitationExperimental treatment 1 intervention
Group B: traditional physiotherapyActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Hip disability and Osteoarthritis Outcome score (HOOS)
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
Time frame
At baseline (day 0)2
Hip disability and Osteoarthritis Outcome score (HOOS)
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
Time frame
After 8 weeks3
Hip disability and Osteoarthritis Outcome score (HOOS)
The HOOS is a 40-item self-report questionnaire with 5 subscales. A normalized score is calculated for each subscale with 0 indicating extreme symptoms and 100 representing no symptoms.
Time frame
After 12 weeksSecondary outcomes
1
Timed Up and GO (TUG)
The test measures the time (in seconds) it takes a patient to get up from a chair, walk 3 meters, reverse and sit back in the chair. It can be performed without aids or with the aid usually used by the patient to walk.
Time frame
After 8 weeks2
Timed Up and GO (TUG)
The test measures the time (in seconds) it takes a patient to get up from a chair, walk 3 meters, reverse and sit back in the chair. It can be performed without aids or with the aid usually used by the patient to walk.
Time frame
After 12 weeks3
Harris Hip Score (HHS)
a multi-disability measurement tool, validated and translated into Italian, composed of a questionnaire and a specific clinical examination which has the aim of evaluating ADL and function in subjects with hip pathology
Time frame
After 8 weeks4
Harris Hip Score (HHS)
a multi-disability measurement tool, validated and translated into Italian, composed of a questionnaire and a specific clinical examination which has the aim of evaluating ADL and function in subjects with hip pathology
Time frame
After 12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov